Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 24;18(3):101034.
doi: 10.1016/j.waojou.2025.101034. eCollection 2025 Mar.

WAO - ARIA consensus on chronic cough: Executive summary

Affiliations
Review

WAO - ARIA consensus on chronic cough: Executive summary

Philip W Rouadi et al. World Allergy Organ J. .

Abstract

Acute cough is a highly prevalent symptom in clinical practice. Chronic cough is a complex disease with significant impact on quality of life. The mechanistic pathways of chronic cough in cough-comorbid clinical phenotypes are elusive. Mounting evidence suggests presence of a hypersensitive cough reflex and implication of transient receptor potential channels and P2X receptors in cough neuronal pathways. Previously, the World Allergy Organization (WAO)/Allergic Rhinitis and its Impact on Asthma (ARIA) Joint Committee on Chronic Cough published updated experimental and clinical data on chronic cough, in addition to a multidisciplinary care pathway approach to its management. The goal of this manuscript is to provide clinicians with a succinct summary of chronic cough pathophysiology, clinical phenotypes, and management strategies in both primary and cough specialty care. This executive summary is a primer for clinicians on chronic cough. Increasing awareness on the topic among primary care physicians will improve the outcome of management of patients with chronic cough.

Keywords: Chronic cough; Gastroesophageal reflux disease; Hypersensitive cough reflex; Lower airway disease; Multifactorial chronic cough; Neuromodulators; Primary care physician; Refractory chronic cough; Unexplained chronic cough; Upper airway disease.

PubMed Disclaimer

Conflict of interest statement

Talal Nsouli: speaker for AstraZeneca. Jonathan A Bernstein: Merck and GSK related to chronic cough. Georges S Juvelekian: speaker for AstraZeneca, Abbott, Boehringer Ingelheim, Sanofi Aventis, Organon, Novartis, and Pfizer. Member of the Advisory board of AstraZeneca, Novartis, and Pfizer. Pete Smith: PI/Consultant GSK, Sanofi Regeneron, Viatris. Glenis Scadding: Honoraria for articles and speaker for GSK, advisory boards for GSK, ALK, Bayer, Chiesi, GlaxoSmithKline, Haleon, Noucor, Sanofi- Regeneron, and Viatris. Chair of BSACI rhinitis guidelines, Scientific Chief Editor, Rhinology Section of Frontiers in Allergy, Vice President, and AR lead for EUFOREA, and Chair/member Data Monitoring Committees on SLIT for ALK. Scientific Chief Editor, Rhinology Section, Frontiers in Allergy. L Klimek (LK) has received research grants from Allergy Therapeutics/Bencard, Great Britain/Germany; ALK-Abelló, Denmark; Allergopharma, Germany; Aimmune, USA; ASIT Biotech, Belgium; AstraZeneca, Sweden, Bionorica, Germany; BioNTech, Germany, Biomay, Austria, Boehringer Ingelheim, Germany, Circassia, USA; Chiesi, Italy; Cytos, Switzerland; Curalogic, Denmark; HAL, Netherlands; Lofarma, Italy; Menarini, Italy; MSD, USA, Viatris/Mylan, USA; Novartis, Switzerland, Leti, Spain; ROXALL, Germany; GlaxoSmithKline (GSK), Great Britain; Sanofi, France; Stallergenes, France; Thermofisher, USA and/or has served on the speaker's bureau or was consulting for the above mentioned pharmaceutical companies. Alessandro Fiocchi: Member of an advisory board: Abbott S.A., Danone, Ferrero SpA, Sponsored research: Ferrero SpA, Novartis S.A., Astrazeneca S.A, Vertex S.A., GSK S.A., Sanofi S.A., DVB S.A. Pedro Giavina-Bianchi: speaker and member for advisory board for: AstraZeneca, Abbvie, CSL Behring, GSK, Novartis, Sanofi, Takeda/Shire.

Figures

Fig. 1
Fig. 1
Cough definition according to chronology of symptom, diagnostic workup, and response to management.
Fig. 2
Fig. 2
“Propeller” model for management of chronic cough in primary (central circle) and cough specialty (propeller “blades”) care. ACO (asthma COPD overlap), AR (allergic rhinitis), CA (classic asthma), CB (chronic bronchitis), COPD (chronic obstructive pulmonary disease), CRS (chronic rhinosinusitis), CVA (cough variant asthma), GERD (gastroesophageal reflux disease), LHR (laryngeal hyperresponsiveness), NAEB (non-asthmatic eosinophilic bronchitis), NP (nasal polyp), OSA (obstructive sleep apnea), PCPs (primary care physicians), RCC (refractory chronic cough), UCC (unexplained chronic cough).

References

    1. Rouadi PW, Idriss SA, Bousquet J, Laidlaw TM, Azar CR, Al-Ahmad MS. WAO-ARIA consensus on chronic cough - Part I: role of TRP channels in neurogenic inflammation of cough neuronal pathways. WAO J. 14(12):100617. doi:10.1016/j.waojou.2021.100617. - PMC - PubMed
    1. Rouadi PW, Idriss SA, Bousquet J, Laidlaw TM, Azar CR, Al-Ahmad MS. WAO-ARIA consensus on chronic cough - Part II: phenotypes and mechanisms of abnormal cough presentation - updates in COVID-19. World Allergy Organ J. 14(12):100618. doi:10.1016/j.waojou.2021.100618. - PMC - PubMed
    1. Rouadi P.W., Idriss S.A., Bousquet J., et al. WAO-ARIA consensus on chronic cough – Part III: management strategies in primary and cough-specialty care. Updates in COVID-19. World Allergy Organ J. 2022;15(5) doi: 10.1016/j.waojou.2022.100649. - DOI - PMC - PubMed
    1. Morice A.H., Millqvist E., Bieksiene K., et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1) doi: 10.1183/13993003.01136-2019. - DOI - PMC - PubMed
    1. Hsu J.Y., Stone R.A., Logan-Sinclair R.B., Worsdell M., Busst C.M., Chung K.F. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J. 1994;7(7):1246–1253. doi: 10.1183/09031936.94.07071246. - DOI - PubMed

LinkOut - more resources